2015 Blue Tag Gala

Hyatt at the Bellevue
200 S. Broad St., Philadelphia, PA 19102  map Map

Date:
Oct 17, 6:00 p.m.-11:00 p.m. (ET)

Join us for the 15th Annual Blue Tag Gala, a glamorous evening of dinner and dancing to raise funds for the Comprehensive Sickle Cell Center at The Children’s Hospital of Philadelphia.

The black-tie-invited event starts at 6 p.m. with a silent auction and cocktail reception in the Grand Ballroom at the Hyatt at the Bellevue in Philadelphia, PA. Dinner and dancing to live music will follow at 7 p.m.

The Blue Tag Gala is the largest recurring fundraiser for the Sickle Cell Center and last year raised $200,000 in support of sickle cell disease treatment, care and research for this devastating condition.

Sickle cell disease and the significance of “blue tag”

Sickle cell disease is a group of inherited blood disorders characterized by chronic anemia, pain and complications that can lead to stroke and organ damage. The average life expectancy for individuals with sickle cell disease is 45 years for men, and 55 years for women. In the United States, the disease affects 1 in 400 African-American newborns, and 1 in 1,000-4,000 Hispanic-American newborns.

Current treatment for sickle cell disease includes frequent blood transfusions from donors who, ideally, have the same ethnic background as the patient. Blood donors can guarantee their donation goes to help a patient with sickle cell disease by asking that a "blue tag” be added to their donations. The blue tag notifies the American Red Cross testing lab that the donation should be matched to a patient with sickle cell disease.

Sponsorship opportunities

Sponsorship packages are available at various levels and can be customized to meet your needs. Learn more about sponsorship opportunities for the Blue Tag Gala.

Your generous support will raise funds to fuel patient care and cutting-edge research at the Comprehensive Sickle Cell Center, including groundbreaking investigations that have the potential to cure sickle cell disease before birth. With sufficient philanthropic support, CHOP is just two years away from the first clinical trial of in utero stem cell transplantation, which would revolutionize treatment for sickle cell disease and other immunodeficiency disorders.

Learn who your gift helps

Meet some of our patients at CHOP’s Comprehensive Sickle Cell Center, and learn how our groundbreaking research is leading us closer to a cure for children and adults with this disorder.